Ignite Creation Date:
2024-05-06 @ 4:11 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04900363
Status:
UNKNOWN
Last Update Posted:
2022-10-12
First Post:
2021-04-29
Brief Title:
A Trial of AK112 PD-1VEGF Bispecific Antibody in Patients With NSCLC
Sponsor:
Akeso
Organization:
Akeso
Organization Data
Organization:
Akeso
Class:
INDUSTRY
Study ID:
AK112-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Akeso
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None